Company
SkinBioTherapeutics PLC
LON:SBTX
SkinBioTherapeutics PLC is a life science company focused on skin health. The company’s proprietary platform technology, SkinBiotix ® , is based upon discoveries made at The University of Manchester.
156 stories · page 1 of 8
SkinBioTherapeutics puzzled by share price, says feedback positive for psoriasis treatment
In today’s statement, it said: “The team continues to focus on driving sales of AxisBiotix-Ps".
SkinBioTherapeutics CEO says company still at start of the journey as initial sales of psoriasis product miss expectations
“We're still at a very early stage of the sales journey, however, it's clear from the customer feedback that AxisBiotix-Ps is a product that has already had a very positive impact,” CEO Stuart Ashman told investors
SkinBioTherapeutics beefs up the board
The company has appointed a full-time CFO and an expert in marketing fast-moving consumer goods
SkinBio to use social media influencers to accelerate launch of psoriasis treatment
Psoriasis brand AxisBiotix-Ps is hoped to reach at least 1.2 million people on social media
SkinBioTherapeutics seeks full-time finance chief and NED to guide social media strategy
The company aiming to appoint a replacement CFO early in the second quarter to ensure an orderly handover
Xmas tips contest for 2021 wrapped up by small cap pick
Watch out for the new edition for 2022 coming in the next week or two, including a number of new competitors
SkinBioTherapeutics CEO hails 2021 as 'landmark year'
“We have transformed ourselves from a research and product development business to a commercial one," said CEO Stuart Ashman
Proactive News round-up: SkinBioTherapeutics, Alpha Growth, Afarak....
A selection of the stories appearing today on the Proactive website
SkinBioTherapeutics launches food supplement aimed at alleviating psoriasis
Today is World Psoriasis Day so it's a good day for SkinBio to launch AxisBiotix-Ps in the UK and the US